Insider · CIK 0001202335
David W Gryska
Files at FBRX (Forte Biosciences, Inc.), CELC (Celcuity Inc.), DFTX (Definium Therapeutics, Inc.). First filing Dec 5, 2024, latest Dec 5, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DFTX: Definium Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 18Weak | DFTXbuy Definium Therapeutics, Inc. | $18k 2,500 shares | +14% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | CELC Celcuity Inc. | AGrant or award Common Stock | +893 | $0.00 | $0 | 893 | 7 d ago |
| Jun 12, 2025 | DFTX Definium Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +75,187 | $0.00 | $0 | 75,187 | Jun 16, 2025 |
| Mar 20, 2025 | FBRX Forte Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +31,000 | $0.00 | $0 | 31,000 | Mar 21, 2025 |
| Dec 5, 2024 | DFTX Definium Therapeutics, Inc. | POpen-market purchase Common Shares | +2,500 | $7.17 | $18k | 19,851 | Dec 5, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.